streptomycin has been researched along with Extensively Drug-Resistant Tuberculosis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 11 (73.33) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
Authors | Studies |
---|---|
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
Chen, M; Gao, N; Jiang, JD; Jiang, W; Li, D; Li, Y; Lin, Y; Lu, Y; Si, S; Wan, K; You, X; Zhu, N | 1 |
Doulla, B; Ershova, J; Heinrich, N; Hoelscher, M; Kilale, AM; Kingalu, A; Kisonga, R; Kondo, Z; Lema, Y; Lyamuya, E; Lyimo, J; Mfaume, SM; Mutayoba, BK; Ngowi, BJ; Nkiligi, E; Ntinginya, NE; Pletschette, M; Range, NS | 1 |
Barnwal, RP; De Rosa, M; Pandey, A; Sharma, A; Singh, G; Singla, N | 1 |
Alame Emane, AK; Guo, X; Liu, S; Takiff, HE | 1 |
Chen, YH; Huang, CH; Kuo, CY; Lu, PL; Wang, WH | 1 |
Assam Assam, JP; Eyangoh, S; Fouda, FX; Frank, M; Kuaban, C; Mouafo Tekwu, E; Nolna, D; Ntoumi, F; Penlap Beng, VN; Sidze, LK; Tedom, JC | 1 |
Choi, SB; Jo, KW; Jung, H; Kang, MR; Lee, YS; Shim, TS | 1 |
BaƱuls, AL; Contamin, L; Dang, AD; Nguyen, HQ; Nguyen, HV; Nguyen, NLT; Nguyen, NV; Nguyen, ST; Nguyen, VAT; Tran, THT; Vu, TT | 1 |
Chan, ED; Iseman, MD; Strand, MJ | 1 |
Anand, AA; Balaji, V; Chordia, P; Daley, P; Ganesh, A; George, IA; John, KR; Mathai, D; Michael, JS; Sahni, RD; Sudarsanam, T; Thomas, K | 1 |
Kim, DH; Kim, EK; Kim, HJ; Kim, TH; Kim, YS; Koh, WJ; Kong, SJ; Lee, CH; Lee, KM; Lee, SS; Park, JS; Park, SK; Shim, TS | 1 |
Chang, KC; Leung, CC; Tam, CM; Yew, WW | 1 |
Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
Chang, KC; Kam, KM; Leung, CC; Leung, EC; Leung, WM; Tam, CM; Yew, WW | 1 |
1 review(s) available for streptomycin and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genetic Fitness; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2021 |
14 other study(ies) available for streptomycin and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
Topics: Antitubercular Agents; Dioxanes; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; HEK293 Cells; Humans; Mycobacterium tuberculosis; Oxazoles; Structure-Activity Relationship | 2015 |
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tanzania; Tuberculosis, Multidrug-Resistant | 2022 |
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
Topics: Antitubercular Agents; Ciprofloxacin; Disease Progression; Drug Carriers; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Structure-Activity Relationship; Thiophenes; Toll-Like Receptors | 2021 |
Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Taiwan | 2018 |
Strong decrease in streptomycin-resistance and absence of XDR 12 years after the Reorganization of the National Tuberculosis Control Program in the Central Region of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cameroon; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Risk Factors; Socioeconomic Factors; Streptomycin; Young Adult | 2014 |
Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genes, MDR; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Republic of Korea; Rifampin; Sputum; Streptomycin | 2015 |
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Gene Expression; Genetic Fitness; Genetic Variation; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Ribosomal Proteins; Rifampin; Streptomycin; Vietnam | 2017 |
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Topics: Antitubercular Agents; Cohort Studies; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Prognosis; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2009 |
Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.
Topics: Adolescent; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Hospitals; Humans; India; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Risk; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2010 |
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Korea; Male; Medication Adherence; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Streptomycin; Tuberculosis, Pulmonary; Young Adult | 2010 |
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB?
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Ofloxacin; Streptomycin; Tuberculosis, Pulmonary | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city.
Topics: Adult; Cities; Cluster Analysis; Cohort Studies; Contact Tracing; Extensively Drug-Resistant Tuberculosis; Female; Hong Kong; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prevalence; Retrospective Studies; Streptomycin; Tuberculosis, Multidrug-Resistant; Urban Population | 2013 |